Commonwealth Retirement Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
MCM
CIA
AWM
FP
MFG
AFG
DADC
Commonwealth Retirement Investments's IHE Position: Q2 2026 in Review
Commonwealth Retirement Investments reduced its iShares US Pharmaceuticals ETF (IHE) stake by 9.8% in Q2 2026, selling an estimated $29.1K and leaving 2,967 shares worth $294K. The position accounts for 0.08% of the portfolio, ranked #111.
Commonwealth Retirement Investments first reported a position in IHE in Q4 2024 and has held it in 4 quarters since. The position peaked at $536K in Q4 2024. 91 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Commonwealth Retirement Investments held 2,967 shares of iShares US Pharmaceuticals ETF worth $294K as of Q2 2026.
- Commonwealth Retirement Investments sold 323 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $29.1K.
- iShares US Pharmaceuticals ETF made up 0.08% of Commonwealth Retirement Investments's portfolio in Q2 2026, its #111 holding.
- Commonwealth Retirement Investments first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 4 quarters since.
- Commonwealth Retirement Investments's iShares US Pharmaceuticals ETF position peaked at $536K in Q4 2024.
- 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Commonwealth Retirement Investments's 13F filing for Q2 2026, filed 3 Aug 2026.